Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Breast 2Thoracic 1Plasma cell 1

Conditions

Estrogen Receptor-positive Breast Cancer 1Breast Neoplasms 1

Interventions

Fulvestrant 85Letrozole 79Paclitaxel 76pembrolizumab 72Specimen Handling 67Trastuzumab 62Carboplatin 57Magnetic Resonance Spectroscopy 52ribociclib 49Capecitabine 49Anastrozole 48pertuzumab 46palbociclib 45abemaciclib 41exemestane 40Tamoxifen 40Cyclophosphamide 40Biopsy 39trastuzumab deruxtecan 31Docetaxel 30Radiotherapy 29Taxes 28Gemcitabine 25Blood Specimen Collection 25130-nm albumin-bound paclitaxel 25Surveys and Questionnaires 23olaparib 22Standard of Care 22sacituzumab govitecan 20eribulin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diet, Ketogenic × Breast × 90 days × Clear all
NCT07574671 2026-05-08

Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer

The University of Texas Health Science Center at San Antonio

Phase NA Recruiting
12 enrolled
Breast

Breast Neoplasms

NCT03962647 2026-04-30

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Completed
31 enrolled
Breast

Estrogen Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡